UnitedHealth Group Incorporated
NYSE:UNHMedical - Healthcare Plans
+$3.69 today
- Market cap
- $313.53B
- Beta
- 0.65
- P/E (TTM)
- 30.5
- EPS (TTM)
- $13.24
- Dividend yield
- 2.22%
Volume 17.34M
Average 8.23M
UNH Common Stock Repurchased
Cash spent buying back the company's own shares.
UnitedHealth Group IncorporatedNYSE: UNH
Common Stock Repurchased · Q3 FY2026 · quarter ended Sep 2026
Common stock repurchased turns negative
Q3 FY2026 common stock repurchased was -$3.39B, compared with $4.74B a year earlier. Trailing-twelve-month common stock repurchased was -$9.77B. Over 3 fiscal years it compounded at -7.5% a year.
Context
- Common stock repurchased amounted to 1.2% of revenue in FY2025, down 1.0 pp from a year earlier.
- Common stock repurchased grew in size in 2 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly common stock repurchased holds near -$3.39B or moves back toward the trailing-twelve-month quarterly average of -$2.44B.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Repurchased history
USD · from the cash flow
- Latest · FY2025
- (5.55B) USD
- Year-over-year change
- +38.4%
| Period | Period end | Common Stock Repurchased | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (5.55B) | +38.4% |
| FY2024 | 2024-12-31 | (9B) | -12.5% |
| FY2023 | 2023-12-31 | (8B) | -14.3% |
| FY2022 | 2022-12-31 | (7B) | -40.0% |
| FY2021 | 2021-12-31 | (5B) | — |
Common Stock Repurchased vs competitors
How UNH compares with its peers on the latest reported figures
- UNH's LTM Sep 2026 common stock repurchased of $9.77B is the largest of the 9 companies compared; the peer median is $24.5M.
- Its year-over-year change of +69.2% is the highest of 7, against a peer median of -82.8%.
- Common stock repurchased amounts to 2.2% of revenue for UNH, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $9.77B | +69.2% | -7.5% | 2.2% | |
| LTM Sep 2026 | $2.16B | -45.3% | +4.0% | 1.1% | |
| LTM Sep 2026 | $1.53B | -67.0% | -21.9% | 0.5% | |
| LTM Sep 2026 | $152M | -3.8% | -58.4% | 0.1% | |
| LTM Jun 2026 | $35M | -98.7% | -46.5% | 0.0% | |
| LTM Sep 2026 | $14M | -99.1% | +35.7% | 0.0% | |
| LTM Jun 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding UNH) | $24.5M | -82.8% | -21.9% | 0.0% | |
Competitors are the stored peer set for UNH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 17.29B | 20.12B | 22.38B | 15.24B | 12.81B |
| Depreciation & Amortization | 3.1B | 3.4B | 3.97B | 4.1B | 4.36B |
| Deferred Income Tax | (814M) | (673M) | (245M) | (296M) | (989M) |
| Stock-Based Compensation | 800M | 925M | 1.06B | 1.02B | 971M |
| Change in Working Capital | 1.52B | 2.25B | 1.64B | (808M) | 2.28B |
| Accounts Receivables | (1B) | (2.52B) | (3.11B) | (1.44B) | 0 |
| Inventory | (1.03B) | 0 | 1.04B | 0 | 0 |
| Accounts Payables | 3.86B | 1.96B | 3.52B | 2.46B | 0 |
| Other Working Capital | (310M) | 2.81B | 203M | (1.83B) | 2.28B |
| Other Non-Cash Items | 447M | 188M | 258M | 4.95B | 265M |
| Operating Cash Flow | 22.34B | 26.21B | 29.07B | 24.2B | 19.7B |
| Capital Expenditures | (2.45B) | (2.8B) | (3.39B) | (3.5B) | (3.62B) |
| Acquisitions (Net) | (4.82B) | (21.46B) | (10.14B) | (13.41B) | (4.51B) |
| Purchases of Investments | (1.84B) | (18.83B) | (18.31B) | (27.31B) | 0 |
| Sales of Investments | 15.3B | 11.99B | 16.54B | 27.83B | 361M |
| Other Investing Activities | (16.55B) | 2.62B | (275M) | (4.15B) | (915M) |
| Investing Cash Flow | (10.37B) | (28.48B) | (15.57B) | (20.53B) | (8.69B) |
| Debt Repayment | 2.48B | 12.54B | 4.28B | 14.66B | 726M |
| Common Stock Issued | 1.36B | 1.25B | 1.35B | 1.85B | 0 |
| Common Stock Repurchased | (5B) | (7B) | (8B) | (9B) | (5.55B) |
| Dividends Paid | (5.28B) | (5.99B) | (6.76B) | (7.53B) | (7.92B) |
| Other Financing Activities | 344M | 3.43B | (2.4B) | (3.49B) | 1.09B |
| Financing Cash Flow | (7.46B) | 4.23B | (11.53B) | (3.51B) | (11.64B) |
| Effect of Forex Changes | (62M) | 34M | 97M | (280M) | 3.44B |
| Net Change in Cash | 4.45B | 1.99B | 2.06B | (115M) | 2.81B |
| Free Cash Flow | 19.89B | 23.4B | 25.68B | 20.71B | 16.08B |
UnitedHealth Group Incorporated
NYSE:UNH
Intrinsic Alpha fair value
Locked
Current Price
$349.91
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.